Other events, links, news… Archive


CRISPR and Beyond, Wellcome Genome Campus, UK – Sep. 2 to 4, 2019

CRISPR and beyond – perturbations at scale to understand genomes

02 – 04 September 2019, Wellcome Genome Campus, UK

The rapid advances of CRISPR/Cas-based technologies and DNA synthesis now make it possible to modulate genomes with relative ease. These tools can help us understand how genetic variation impacts phenotype and answer important long-standing questions in biology that also impact human health, laying the foundations for precision medicine for heritable diseases and cancer treatment.
This conference will bring together biomedical researchers working on high throughput screening, genome engineering, and/or variant effect interpretation, to explore these advances.
Early Bird discount is available until 11 June 2019. A limited number of bursaries are available for PhD students to attend the meeting.
Please feel free to forward this message on to colleagues who may also have an interest in this conference.

Scientific sessions include:
  • Understanding impact of coding variants
  • Measuring consequences of non-coding variation
  • Screens for gene function in cells
  • Assaying gene function in organisms
  • Gene and drug function in disease
  • Interactions with genes, drugs, and environment
  • New technology for readouts and perturbations
John Doench
Broad Institute of MIT and Harvard, USA
Jolanda van Leeuwen
University of Lausanne, Lausanne, Switzerland
Leopold Parts
Wellcome Sanger Institute, UK
Lea Starita
University of Washington, USA
Brit Adamson
University of Princeton, USA

Brenda Andrews
University of Toronto, Canada

Michael Boutros
DKFZ Heidelberg, Germany

Ellen Bushell
Umea University, Sweden

Ulrich Elling
Institute of Molecular Biology, Austria

Douglas Fowler
Unversity of Washington, USA

Molly Gasperini
University of Washington, USA

Maya Ghoussaini
Open Targets, UK

Luke Gilbert

Emma Haapaniemi
University of Oslo, Norway

Ben Lehner
Centre for Genomic Regulation, Spain

James McFarland
Broad Institute, USA

Fritz Roth
University of Toronto, Canada

Jussi Taipale
University of Cambridge, UK

Sibylle Vonesch
EMBL, Germany

Yanli Wang
Institute of Biophysics CAS, China

Poster: https://coursesandconferences.wellcomegenomecampus.org/wp-content/uploads/2018/12/CRISPR_2019_A4_Poster.pdf 


Thesis defense of Harmonie Dehaene, March 8, 2019 – 16:00 Aud. A, Génopode


D.Day 2019: Wednesday 10th April – Auditoire Yersin, CHUV

The ADAS is excited to invite you all to the 15th edition of the

D.Day 2019

Wednesday 10th April
Auditoire Yersin – CHUV

Come discover what your neighbours are working on!

Registration deadline is until March 20th!


The D.Day is our annual PhD event at UNIL, organised by ADAS and supported by the Doctoral School of the FBM. During this day, invited speakers present their research on various topics, and PhD students and Post-docs are given the opportunity to share and present their work as posters or also as oral presentations! Of course, the event is followed by an aperitif!


With exciting talks by this year’s distinguished guest speakers:


Francesca Siclari – Research center for the sleep, CHUV, Switzerland

Carlos Guillén Viejo– Département of Biochimistry and molecular biology, Complutense University Madrid, Spain

Wendy Russell – Rowett Institut, University of Aberdeen, UK

Jonathan Cooper – Wolfson Chair of Engineering, University of Glasgow, UK


Why come to the D.Day?

* Easy credits! 0.5 ECTS if you present a poster and 1.0 ECTS if you are selected for a short talk

* Networking experience! with your colleagues, our sponsors and our extra guests from biotech startups

* Cash Prize! for best talk and best poster!


Check out the full program and other info about the D.Day 2019 on our website www.unil.ch/dday

Fill in the registration form if you would like to come! 


The event is open to all, therefore even if you don’t have a poster, you are still more than welcome to come! So don’t hesitate to register!

FMB is composed from different horizons, so if you are an engineer or working on public health or any other topic related to life science, please come and share with us your work!

Programme           http://wp.unil.ch/dday/program/ 

Further information   http://wp.unil.ch/dday/


ADAS Committee





Rigi-workshop «Editing the code of human life – biological, ethical and legal perspectives», Apr. 25-27, 2019 (Deadline Feb. 28)

The Platform Biology of the Swiss Academy of Sciences co-organizes the upcoming Rigi-workshop «Editing the code of human life – biological, ethical and legal perspectives». The workshop takes place from April 25 to 27, 2019 and is open to all PhD and master students and to Postdocs. We encourage all interested persons from any discipline to apply: http://biologie.scnat.ch/rigiworkshop

«Editing the code of human life – biological, ethical and legal perspectives»
Rigi-Workshop, 25 – 27 April 2019, Rigi Kulm

Genome editing enables the deletion, modification or introduction of gene sequences. With the discovery of the CRISPR/Cas9 system it became a method which is broadly applicable and highly specific, also in humans. For biologists it is a new, powerful and important tool, lawyers are confronted with regulatory challenges and for ethicists it raises different questions of how and for what purposes the technology should be applied. During the workshop a particular focus will be set on the context of reproductive medicine, where we will compare the new challenges with similar questions that previously confronted our society.

The workshop aims to bring together researchers from different disciplines to learn from each other and to understand the different challenges and opportunities associated with human genome editing.

Workshop format:
Lectures, case studies, plenary discussions, poster sessions

Prof. Dr. Isabel Roditi, Institute of Cell Biology, University of Bern; Prof. Dr. Claudia Seitz, Faculty of Law, University of Basel; Dr. Anna Deplazes Zemp, Institute of Biomedical Ethics and History of Medicine, University of Zurich

PhD students from all Swiss institutions of Higher Learning are most strongly encouraged to apply. We aim to have participants from different research areas (biology, ethics, law and other). Applications from Master students and Postdocs are also considered.

Please register online and submit an abstract of your research and a short letter of motivation for attending before February 28, 2019. More Information: http://biologie.scnat.ch/rigiworkshop

Contact your doctoral school for the accreditation of ETCS.
Organizers: Isabel Roditi (Institute of Cell Biology, University of Bern), Luzia Guyer and Pia Stieger (Swiss Academy of Sciences)

Lauréats Prix Louis-Jeantet 2019


Les Prix Louis-Jeantet 2019 sont attribués à LUIGI NALDINI, directeur du San Raffaele Telethon Institute for Gene Therapy et professeur à l’Université San Raffaele à Milan (Italie), et à BOTOND ROSKA, directeur cofondateur de l’Institut d’ophtalmologie moléculaire et clinique de Bâle (IOB), Suisse.

L’Italien LUIGI NALDINI reçoit le Prix Jeantet-Collen pour la médecine translationnelle 2019 pour son travail de pionnier sur la thérapie génique, du laboratoire au chevet du patient.

Technique d’avenir, la thérapie génique vise à remplacer des gènes défaillants qui sont à l’origine de diverses maladies. Luigi Naldini est internationalement reconnu pour avoir joué un rôle de pionnier dans ce domaine. Il a développé de nouveaux vecteurs permettant de transporter, avec plus de sûreté et d’efficacité, des gènes sains dans les cellules cibles. Ses travaux ont déjà permis de traiter avec succès une centaine de jeunes patients.

Luigi Naldini utilisera le montant du prix pour poser les bases d’une nouvelle génération de thérapie génique, utilisant des cellules souches hématopoïétiques (qui sont à l’origine des cellules sanguines).

BOTOND ROSKA, d’origine hongroise, reçoit le Prix Louis-Jeantet de médecine 2019 pour ses découvertes sur les principes de base du traitement de l’information visuelle et le développement de stratégies thérapeutiques, telle que la thérapie génique, pour le traitement des troubles de la rétine.

Traiter les personnes mal ou non voyantes est un réel défi pour la médecine. Botond Roska a entrepris de le relever. Son équipe a étudié les interactions entre certains types de cellules du système visuel qui sont à l’origine de cécités héréditaires, ainsi que les circuits neuronaux dans lesquels ces cellules interviennent. Cela lui a permis d’élucider les mécanismes impliqués dans ces pathologies et de proposer de nouvelles thérapies pour les traiter.

Botond Roska va utiliser le montant du prix pour développer des méthodes permettant de comprendre l’architecture fonctionnelle de la rétine humaine saine et malade.

La FONDATION LOUIS-JEANTET dote chacun des deux prix d’une somme de CHF 500’000, dont CHF 450’000 sont destinés à financer la poursuite des travaux des lauréats et CHF 50’000 leur sont remis à titre personnel.


Pour de plus amples informations sur les lauréats et leurs travaux : www.jeantet.ch



Tuesday Dec. 11, 2018 PacBio Day Lausanne

Tuesday 11 December 2018, 13h30 – 17h

Génopode Aud. B

Registration: tim.hander@witec.ch